Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Conduit Pharmaceuticals Inc. - Common Stock (NQ: CDT )

0.1533 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,568
Open 0.1533
Bid (Size) 0.1533 (33)
Ask (Size) 0.1571 (10)
Prev. Close 0.1533
Today's Range 0.1533 - 0.1533
52wk Range 0.1326 - 10.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today?
Conduit Pharmaceuticals stock is up on Wednesday alongside heavy trading following an invest update on CDT shares. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning! 
Via InvestorPlace

Performance

YTD
-96.73%
-96.73%
1 Month
-34.12%
-34.12%
3 Month
-94.94%
-94.94%
6 Month
-94.84%
-94.84%
1 Year
-98.52%
-98.52%

More News

Read More
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024
Via InvestorPlace
Why Is Conduit Pharmaceuticals (CDT) Stock Up 123% Today?
Via InvestorPlace
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
From Conduit Pharmaceuticals
Via GlobeNewswire
S&P 500 Gains 1%; US Jobless Claims Fall To 230,000
Via Benzinga
Topics Stocks
Exposures US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
From Conduit Pharmaceuticals
Via GlobeNewswire
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
Via Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
What Happened With Conduit Pharmaceuticals (CDT) Stock Today?
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?
Via InvestorPlace
Why Is Autonomix Medical (AMIX) Stock Down 17% Today?
Via InvestorPlace
Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
From Conduit Pharmaceuticals
Via GlobeNewswire
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Conduit Pharmaceuticals to Join Russell 3000® Index
From Conduit Pharmaceuticals
Via GlobeNewswire
A Presidio Property Trust Major Investment To Be Part of Russell 2000®
From Presidio Property Trust, Inc.
Via GlobeNewswire
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q1 2024
Via InvestorPlace
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
From Conduit Pharmaceuticals
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.